Spring to Life Conference on Immuno-Oncology: Harnessing the Power of our Immune System in Cancer Therapy

6th Annual Spring to Life Conference on Immuno-Oncology: Harnessing the Power of our Immune System in Cancer Therapy is organized by myMedEd and will be held on May 11, 2019 at Albany Marriott, Albany, New York, United States of America.

Target Audience:
The target audience for this conference is hematologists, oncologists, nurse practitioners, physician assistants, oncology nurses, family, and primary care practitioners, allied health professionals, and any other interested cancer care providers. Healthcare professionals are welcome and encouraged to participate in the afternoon patient-centered sessions.

Accreditation:
Physician and Allied Health Professional Accreditation:
The Center for Emergency Medical Education (CEME) designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Center for Emergency Medical Education (CEME) designates this live activity for a maximum of 3.75 hours of participation for continuing education for allied health professionals.

Nurse and Social Worker Accreditation:
?Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 3.75 continuing education contact hours through the California Board of Registered Nursing. This document must be retained by the licensee for a period of four years after the course ends.

Program Description:
Spring to Life™ Conference on Immuno-Oncology: Harnessing the Power of our Immune System in Cancer Therapy is an accredited educational program developed by New York Oncology Hematology (NYOH), in collaboration with the Center for Emergency Medical Education (CEME), the Leukemia & Lymphoma Society, and a panel of expert faculty from the academic, research, and community practice settings.

Overview:
With programming for both healthcare professionals and the community, the goal of this 1-day activity is to bring together cancer care providers and members of the community, including patients, survivors, their family, and caregivers, to gain an up-to-date understanding of blood cancers, including ongoing research, clinical management, and emerging therapies. The program also provides perspectives on the impact of cancer on the lives of patients and families. The 2019 conference goal is to inform, update, and improve practitioners’ understanding of existing and emerging immunologic therapies for cancer. The theme of the afternoon patient program is Hopefulness During Change, Aging, Illness, and Loss.

Healthcare professionals are welcome and encouraged to participate in the afternoon patient-centered sessions.

Learning Objectives:
After completing this activity, participants should be better prepared to:
• Review the basic science of the immune system interactions with cancer.
• Discuss the existing and emerging data on checkpoint inhibition therapy.
• Evaluate a variety of historical, contemporary and emerging immunotherapy approaches through the paradigm of cutaneous melanoma.
• Describe the evolving paradigms and data on allogeneic hematopoietic stem cell transplantation.
• Review the data on current and emerging Chimeric Antigen Receptor T cell (CAR-T) and other cellular therapy constructs.